Details for New Drug Application (NDA): 216335
✉ Email this page to a colleague
The generic ingredient in LACOSAMIDE is lacosamide. There are twenty-two drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the lacosamide profile page.
Summary for 216335
Tradename: | LACOSAMIDE |
Applicant: | Aspiro |
Ingredient: | lacosamide |
Patents: | 0 |
Pharmacology for NDA: 216335
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Suppliers and Packaging for NDA: 216335
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LACOSAMIDE | lacosamide | SOLUTION;INTRAVENOUS | 216335 | ANDA | Camber Pharmaceuticals, Inc. | 31722-203 | 31722-203-31 | 10 VIAL, GLASS in 1 CARTON (31722-203-31) / 20 mL in 1 VIAL, GLASS (31722-203-20) |
LACOSAMIDE | lacosamide | SOLUTION;INTRAVENOUS | 216335 | ANDA | NorthStar RxLLC | 72603-263 | 72603-263-02 | 10 VIAL, GLASS in 1 CARTON (72603-263-02) / 20 mL in 1 VIAL, GLASS (72603-263-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 200MG/20ML (10MG/ML) | ||||
Approval Date: | Sep 14, 2022 | TE: | AP | RLD: | No |
Complete Access Available with Subscription